![]() |
市場調查報告書
商品編碼
2133627
2034年生物工程工業化學品市場預測-全球分析(依化學品類型、生物生產平台、原料、工程方法、應用、最終用戶及地區分類)Bioengineered Industrial Chemicals Market Forecasts to 2034 - Global Analysis By Chemical Type, Biological Production Platform, Feedstock, Engineering Approach, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球生物工程工業化學品市場規模將達到 91 億美元,並在預測期內以 13.0% 的複合年成長率成長,到 2034 年將達到 242 億美元。
生物工程工業化學品是指利用基因改造的微生物、酵素或無細胞系統,透過生物過程將醣類、生質能和廢棄物等可再生原料轉化為永續的化學產品,從而永續生產的有機酸、醇類、溶劑、聚合物、界面活性劑和其他中間體化合物。這些生物基化學品透過微生物發酵、生物催化或合成生物學技術生產,減少了對化石燃料衍生原料的依賴。
促進因素:強制取代化石衍生化學品。
日益成長的監管壓力促使企業減少對化石燃料衍生化學品的依賴,同時企業也加大力度減少碳排放,加速了透過生物工程取得工業化學品的進程。化學品製造商、消費品公司和包裝製造商正日益尋求包含可再生原料的材料,以滿足永續發展目標、ESG(環境、社會和治理)要求以及產品層面的碳減排目標。促進生物基和可生物分解材料的法規正在擴大其在化學品、包裝、紡織品、個人護理和聚合物等領域的應用範圍。因此,企業正在投資發酵能力、合成生物學平台和可再生原料加工技術,以開發商業性化規模生產的傳統石油化學產品替代方案。
阻礙因素:生產成本的競爭力差距
生物工程化學品與傳統石油化學產品之間持續存在的成本競爭力差距,是其廣泛市場應用的一大障礙。基於發酵的生產通常需要專用生物反應器、受控制程環境、下游提純以及高能耗的分離工藝,從而推高了整體生產成本。與擁有完善基礎設施和規模經濟優勢的成熟石油化工設施相比,原料成本和相對有限的生產規模會進一步削弱其經濟可行性。如果沒有政策獎勵、碳定價機製或消費者願意支付永續性溢價,生物工程化學品將難以與大規模生產的通用化學品競爭。
機會:碳捕獲與廢棄物衍生原料
碳捕獲和廢棄物衍生原料為擴大永續化學品生產提供了重要機遇,同時也能提高資源利用效率並減少溫室氣體排放。利用捕獲的二氧化碳、工業廢氣、農業殘渣、城市固體廢物和其他廢棄物流的技術可以為生物工程化學品的生產提供替代碳源。將鋼鐵廠和工業設施產生的富碳排放物轉化為高價值化學品和中間體的工業氣體發酵技術正吸引商業性的注意。將廢棄物利用、碳捕獲和生物製造結合,可以建立循環價值鏈,同時減少對糧食農業原料和化石燃料的依賴。
威脅:農產品原物料價格波動
農產品價格波動對依賴玉米、甘蔗、植物油和其他生物來源原料的生物工程化學品生產商構成重大威脅。天氣現象、乾旱、作物產量波動、地緣政治不穩定、運輸成本、大宗商品市場的投機行為都會對原物料採購成本產生顯著影響。與食品生產、動物飼料和生質燃料產業的競爭可能會進一步加劇供應緊張,並為原料分配帶來挑戰。不斷上漲的農業投入成本可能會削弱生物工程化學品相對於石油化學產品的價格競爭力,尤其是在客戶對生產成本高度敏感的大宗商品市場。
新冠疫情的影響
新冠疫情擾亂了農業原料、特種原料、發酵投入品和生物製程設備等價值鏈,為生物工程化學品生產商帶來了暫時的挑戰。然而,這場危機也凸顯了靈活的國內生物製造能力在藥品、疫苗和生物技術生產方面的戰略價值,尤其是在快速發展和規模化生產方面。隨後,各國政府和私人投資者加強了對國內具有韌性的生物製造基礎設施和先進生物技術平台的支持。隨著對供應鏈安全、永續生產以及減少對地理集中型生產網路的依賴的日益重視,對生物工程化學品和工業生物技術的長期投資也得到了加強。
在預測期內,「生物基有機酸」細分市場預計將佔據最大的市場佔有率。
預計在預測期內,生物基有機酸領域將佔據最大的市場佔有率,這主要得益於乳酸、檸檬酸和琥珀酸等產品的成熟大規模發酵過程。這些有機酸的應用領域十分廣泛,包括食品飲料、醫藥、個人護理、工業化學品和生物基聚合物等。市場對聚乳酸(PLA)和其他永續材料的需求不斷成長,為生物基酸生產商創造了更多下游市場機會。完善的生產基礎設施、公認的產品功能以及發酵製程經濟效益的提升,預計將進一步鞏固該領域的市場領先地位。
預計在預測期內,微生物發酵領域將實現最高的複合年成長率。
在預測期內,微生物發酵領域預計將呈現最高的成長速度,主要得益於代謝工程、合成生物學、菌株最佳化和精準發酵技術的快速發展。這些進步使得微生物能夠利用可再生和替代原料生產日益複雜的化學品,同時提高產量並降低加工需求。生物反應器設計、連續發酵、下游製程和製程自動化方面的進步進一步提升了商業性化規模化生產的能力。工業生物技術投資的增加以及對永續替代化學品日益成長的需求,預計將加速微生物發酵平台在各種化學品製造應用中的普及。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其完善的發酵基礎設施、豐富的農業原料供應、先進的生物技術能力以及政府對國內生物製造的大力支持。美國擁有成熟的生物技術公司、研究機構、化學品製造商和創業投資人生態系統,致力於開發永續的生產平台。BASF、Genomatica 和 Ginkgo Bioworks 等公司為該地區的創新和商業化能力做出了貢獻。對可再生化學品、合成生物學和國內製造能力的投資增加,將進一步增強北美的競爭力。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度、日本、韓國和東南亞等地區化學品製造、生物技術能力和工業生產的快速擴張。各國政府正透過投資計畫和政策舉措,加強對生物製造、合成生物學、可再生化學品和永續工業發展的支持力度。該地區龐大的消費群和不斷擴張的製造業,正在催生對生物基材料和特殊化學品的強勁需求。農業資源的日益豐富、生物技術基礎設施的完善以及企業對永續發展承諾的不斷增強,預計將加速該地區的市場擴張。
According to Stratistics MRC, the Global Bioengineered Industrial Chemicals Market is accounted for $9.1 billion in 2026 and is expected to reach $24.2 billion by 2034 growing at a CAGR of 13.0% during the forecast period. Bioengineered industrial chemicals refer to sustainably produced organic acids, alcohols, solvents, polymers, surfactants, and other intermediate compounds manufactured through biological processes using engineered microorganisms, enzymes, or cell-free systems that convert renewable feedstocks such as sugars, biomass, or waste streams into valuable chemical products. These bio-based chemicals are produced via microbial fermentation, biocatalysis, or synthetic biology approaches that reduce reliance on fossil-based feedstocks.
Driver: Fossil-Based Chemical Substitution Mandates
Increasing regulatory pressure to reduce dependence on fossil-derived chemicals and growing corporate carbon-reduction commitments are accelerating procurement of bioengineered industrial chemicals. Chemical manufacturers, consumer goods companies, and packaging producers are increasingly seeking renewable-content materials to meet sustainability targets, ESG expectations, and product-level carbon reduction objectives. Regulations promoting bio-based and biodegradable materials are expanding addressable applications across chemicals, packaging, textiles, personal care, and polymers. Consequently, companies are investing in fermentation capacity, synthetic biology platforms, and renewable feedstock processing to develop commercially scalable alternatives to conventional petrochemical products.
Restraint: Production Cost Competitiveness Gap
The persistent cost competitiveness gap between bioengineered chemicals and conventional petrochemical alternatives remains a major barrier to widespread market adoption. Fermentation-based production frequently requires specialized bioreactors, controlled processing environments, downstream purification, and energy-intensive separation processes, increasing overall manufacturing costs. Feedstock expenses and relatively limited production scale can further weaken economics compared with mature petrochemical facilities benefiting from established infrastructure and economies of scale. Without supportive policy incentives, carbon pricing, or customer willingness to pay sustainability premiums, bioengineered chemicals may face difficulty competing in large-volume commodity chemical applications.
Opportunity: Carbon Capture and Waste-Derived Feedstocks
Carbon capture and waste-derived feedstocks offer significant opportunities to expand sustainable chemical production while improving resource efficiency and reducing greenhouse gas emissions. Technologies using captured carbon dioxide, industrial off-gases, agricultural residues, municipal waste, and other waste streams can provide alternative carbon sources for bioengineered chemical manufacturing. Industrial gas fermentation is gaining commercial interest for converting carbon-rich steel mill and industrial emissions into valuable chemicals and intermediates. Integration of waste utilization, carbon capture, and biomanufacturing can create circular value chains while reducing reliance on food-based agricultural feedstocks and fossil resources.
Threat: Agricultural Commodity Feedstock Price Cycles
Fluctuations in agricultural commodity prices represent a significant threat to bioengineered chemical manufacturers that depend on corn, sugarcane, vegetable oils, and other biological feedstocks. Weather events, droughts, changing crop yields, geopolitical disruptions, transportation costs, and commodity-market speculation can substantially affect feedstock procurement expenses. Competition with food production, animal feed, and biofuel industries can further tighten supply and create feedstock allocation challenges. Rising agricultural input costs can weaken the price competitiveness of bioengineered chemicals against petrochemical alternatives, particularly in commodity markets where customers remain highly sensitive to production costs.
COVID-19 Impact
The COVID-19 pandemic disrupted supply chains for agricultural feedstocks, specialty ingredients, fermentation inputs, and bioprocessing equipment, creating temporary challenges for bioengineered chemical manufacturers. However, the crisis simultaneously demonstrated the strategic value of flexible domestic biomanufacturing capabilities through rapid development and scaling of pharmaceutical, vaccine, and biotechnology production. Governments and private investors subsequently increased support for resilient domestic biomanufacturing infrastructure and advanced biotechnology platforms. Growing emphasis on supply-chain security, sustainable production, and reduced dependence on geographically concentrated manufacturing networks strengthened long-term investment in bioengineered chemicals and industrial biotechnology.
The Bio-Based Organic Acids segment is expected to be the largest during the forecast period
The Bio-Based Organic Acids segment is expected to account for the largest market share during the forecast period, supported by established large-scale fermentation pathways for products such as lactic acid, citric acid, and succinic acid. These organic acids have broad applications across food and beverages, pharmaceuticals, personal care, industrial chemicals, and bio-based polymers. Growing demand for polylactic acid (PLA) and other sustainable materials is creating additional downstream opportunities for bio-based acid producers. Established production infrastructure, recognized product functionality, and improving fermentation economics are expected to reinforce the segment's market leadership.
The Microbial Fermentation segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Microbial Fermentation segment is predicted to witness the highest growth rate, driven by rapid advances in metabolic engineering, synthetic biology, strain optimization, and precision fermentation technologies. These developments are enabling microorganisms to produce increasingly complex chemicals from renewable and alternative feedstocks while improving yields and reducing processing requirements. Advances in bioreactor design, continuous fermentation, downstream processing, and process automation are further supporting commercial scalability. Increasing investment in industrial biotechnology and demand for sustainable chemical alternatives are expected to accelerate deployment of microbial fermentation platforms across diverse chemical manufacturing applications.
During the forecast period, the North America region is expected to hold the largest market share, supported by established fermentation infrastructure, abundant agricultural feedstock availability, advanced biotechnology capabilities, and strong government support for domestic biomanufacturing. The United States has a mature ecosystem of biotechnology companies, research institutions, chemical manufacturers, and venture investors developing sustainable production platforms. Companies such as BASF, Genomatica, and Ginkgo Bioworks contribute to regional innovation and commercialization capabilities. Growing investment in renewable chemicals, synthetic biology, and domestic manufacturing capacity is further strengthening North America's competitive position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid expansion of chemical manufacturing, biotechnology capabilities, and industrial production across China, India, Japan, South Korea, and Southeast Asia. Governments are increasingly supporting biomanufacturing, synthetic biology, renewable chemicals, and sustainable industrial development through investment programs and policy initiatives. The region's large consumer base and expanding manufacturing sectors are generating strong demand for bio-based materials and specialty chemicals. Growing availability of agricultural resources, improving biotechnology infrastructure, and increasing corporate sustainability commitments are expected to accelerate regional market expansion.
Key players in the market
Some of the key players in Global Bioengineered Industrial Chemicals Market include BASF SE, DSM-Firmenich AG, Novonesis A/S, Corbion N.V., Genomatica, Inc., Ginkgo Bioworks Holdings, Inc., Gevo, Inc., LanzaTech Global, Inc., ADM, Cargill, Incorporated, DuPont de Nemours, Inc., Evonik Industries AG, Clariant AG, Braskem S.A., TotalEnergies SE, Covestro AG, Lonza Group Ltd., and Ajinomoto Co., Inc.
In August 2026, BASF launched a bioengineered lactic acid facility dedicated to PLA bioplastic manufacturing applications. The venture expands sustainable material options, enabling lower carbon footprints for food packaging and consumer goods.
In July 2026, Genomatica formed a strategic partnership for commercial-scale production of bio-based butanol. The collaboration accelerates the transition away from petrochemical feeds, offering renewable chemical alternatives for industrial applications.
In June 2026, LanzaTech expanded its industrial fermentation capacity to convert waste gases into ethanol and chemicals. The carbon-capture initiative prevents industrial emissions while delivering sustainable raw materials for circular chemical manufacturing.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.